Intas Pharmaceuticals Ltd - Company Profile
Powered by 
All the data and insights you need on Intas Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Intas Pharmaceuticals Ltd Strategy Report
- Understand Intas Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and commercializes pharmaceutical, and biotechnology products for human and animal diseases. The company’s products target the treatment of central nervous system (CNS), gastroenterology, pain management and cardiovascular diseases among other indications. The company manufactures products in various dosage forms, including tablets, pellets, capsules, effervescent tablets, and parenteral and cytotoxic formulations such as liquid injections, lyophilized injections and ointments. The company operates in over 85 countries with a network of sales, marketing and distribution operations. It enters into strategic alliances with global pharmaceutical companies for the development and distribution of products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company's research and development efforts are centered on creating and selling new products and technologies for various medical fields such as cancer treatment, rheumatology, auto-immune diseases, nephrology, ophthalmology, infectious diseases, and acute medical emergencies. Intas conducts its research and development through its subsidiary, Astron Research, employing over 550 scientists and researchers. Its main areas of focus are developing pharmaceutical formulations and active pharmaceutical ingredients. The company has over 50 patents, as of December 31st 2022.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer